Track Tharimmune Inc. Common Stock — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Tharimmune Inc. Common Stock THAR · Stock Open Tharimmune Inc. Common Stock in new tab

3.54 USD
Add to portfolio
EPS
-3.68
P/B
5.55
ROE
-225.01
Beta
1.45
1M 6M YTD 1Y 2Y 5Y Max
Loading chart...
Key Metrics
Earnings dateJune 3, 2026
EPS-3.68
Book Value0.85
Price to Book5.55
Debt/Equity3.18
% Insiders22.658%
Estimates
Forward P/E-39.50
Forward EPS-0.12

DCF Valuation

Tweak assumptions to recompute fair value for Tharimmune Inc. Common Stock (THAR)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result
Fair Value (DCF)
—
Current Price
—
Upside
—
WACC
—
Terminal PV
—
Σ PV of FCFs
—
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Tharimmune Inc. Common Stock Logo Tharimmune Inc. Common Stock Analysis (THAR)

United States Health Care Official Website Stock

Is Tharimmune Inc. Common Stock a good investment? Tharimmune Inc. Common Stock (THAR) is currently trading at 3.54 USD.

Earnings Schedule: Tharimmune Inc. Common Stock is expected to release its next earnings report on June 3, 2026. The market consensus estimate for Forward EPS is -0.12.

Investor FAQ

Does Tharimmune Inc. Common Stock pay a dividend?

No, it does not currently pay a dividend.

What asset class is Tharimmune Inc. Common Stock?

Tharimmune Inc. Common Stock is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be June 3, 2026. The company currently has a trailing EPS of -3.68.

Company Profile

Tharimmune, Inc. focuses on leveraging Canton Coin and supporting the Canton network to advance institutional blockchain adoption and the digitization of financial markets. It is also involved in the clinical-stage biotech research and development activities. The company was formerly known as Hillstream BioPharma, Inc. and changed its name to Tharimmune, Inc. in September 2023. Tharimmune, Inc. was founded in 2017 and is based in Red Bank, New Jersey.

Exchange Ticker
NMS (United States) THAR
Trades
Dividend History paid per year (USD)
No dividend history available.
Stock Splits
Split Date Split Ratio to 1
Nov. 21, 2023 0.040000
May 28, 2024 0.070000
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion